Health ❯Healthcare ❯Clinical Trials

Obesity Treatments

Tirzepatide Semaglutide Amycretin

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks